Financhill
Sell
43

CPT Quote, Financials, Valuation and Earnings

Last price:
$115.88
Seasonality move :
1.66%
Day range:
$115.87 - $117.48
52-week range:
$102.35 - $127.69
Dividend yield:
3.56%
P/E ratio:
106.57x
P/S ratio:
8.12x
P/B ratio:
2.69x
Volume:
470.3K
Avg. volume:
892.8K
1-year change:
7.52%
Market cap:
$12.4B
Revenue:
$1.5B
EPS (TTM):
$1.09

Earnings Data

Next earnings date for CPT
Aug 01
2025
Most recent earnings per share
$0.36
Beat by $0.08
(May 2/2025)
Consensus Estimate
$0.28
(May 2/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CPT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $393.2M -- -- $0.28 --
05/02/2025 Q1 $388.9M $390.6M $0.36 $0.28 $0.08
02/06/2025 Q4 $386.2M $386.3M $0.37 $0.42 -$0.05
10/31/2024 Q3 $389.4M $387.2M -$0.04 $0.28 -$0.32
08/01/2024 Q2 $385.4M $387.2M $0.40 $0.37 $0.03
05/02/2024 Q1 $385.8M $383.1M $0.77 $0.36 $0.41
02/01/2024 Q4 $387.3M $387.6M $2.03 $0.42 $1.61
10/26/2023 Q3 $390.9M $390.8M $0.44 $0.39 $0.05
08/03/2023 Q2 $383.9M $385.5M $0.84 $0.34 $0.50
04/27/2023 Q1 -- $378.2M $0.39 -- --
02/02/2023 Q4 -- $375.9M $0.42 -- --
10/27/2022 Q3 -- $373.8M $0.27 -- --
07/28/2022 Q2 -- $361.7M $4.54 -- --
04/28/2022 Q1 -- $311.4M $0.76 -- --
02/03/2022 Q4 -- $305.4M $2.02 -- --
10/28/2021 Q3 -- $294.1M $0.29 -- --
07/29/2021 Q2 -- $276.5M $0.30 -- --
04/29/2021 Q1 -- $267.6M $0.31 -- --
02/04/2021 Q4 -- $261.6M $0.29 -- --
10/29/2020 Q3 -- $265.7M $0.35 -- --
07/30/2020 Q2 -- $250.7M $0.17 -- --
05/07/2020 Q1 -- $265.9M $0.43 -- --
01/30/2020 Q4 -- $263.5M $0.95 -- --
10/31/2019 Q3 -- $260.7M $0.44 -- --
07/25/2019 Q2 -- $255.8M $0.43 -- --
05/02/2019 Q1 -- $248.6M $0.40 -- --
01/31/2019 Q4 -- $244.9M $0.41 -- --
10/25/2018 Q3 -- $241.8M $0.40 -- --
08/02/2018 Q2 -- $237.1M $0.40 -- --
05/03/2018 Q1 -- $230.7M $0.41 -- --
02/01/2018 Q4 -- $229.8M $0.91 -- --
10/26/2017 Q3 -- $228.2M $0.38 -- --
07/27/2017 Q2 -- $223.4M $0.43 -- --
05/04/2017 Q1 -- $219.5M $0.39 -- --
02/07/2017 Q4 -- $217.1M $0.45 -- --
10/28/2016 Q3 -- $220.2M $3.21 -- --
07/28/2016 Q2 -- $221.5M $4.92 -- --
04/29/2016 Q1 -- $217.6M $0.46 -- --
01/28/2016 Q4 -- $215M $0.67 -- --
10/30/2015 Q3 -- $212.6M $0.41 -- --
07/30/2015 Q2 -- $206.4M $0.40 -- --

Camden Property Trust Earnings Questions

  • How Much did Camden Property Trust Generate in Revenue Last Quarter?

    Camden Property Trust reported $390.6M worth of top line sales in its most recent quarter.

  • Did Camden Property Trust Beat Earnings Last Quarter?

    Camden Property Trust announced earnings per share of $0.36 which represents a beat of analyst forecast a $0.28 per share.

  • Is Camden Property Trust Profitable?

    Camden Property Trust reported $240.6M that represents $2.22 per share over the last quarter.

  • What is the Analyst Consensus for Camden Property Trust EPS Next Year?

    Camden Property Trust's earnings are forecast to decrease from $1.50 per share to $1.80 per share next year representing a decrease of -21.75%.

  • When is Camden Property Trust's Earnings Date?

    Camden Property Trust's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 21.6% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 1.69% over the past day.

Sell
43
TNXP alert for Jun 17

Tonix Pharmaceuticals Holding [TNXP] is down 4.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock